Analysis of suicidality in pooled data from 2 double-blind, placebo-controlled aripiprazole adjunctive therapy trials in major depressive disorder

Journal of Clinical Psychiatry

Volumn 72, Issue 4, 2011, Pages 548-555

  Weisler, R H ^a   Khan, A ^a,b   Trivedi, M H ^c   Yang, H ^d   Eudicone, J M ^d   Pikalov, A ^e   Tran, Q V ^e   Berman, R M ^d   Carlson, B X ^d  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Research Center   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

^e OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; PLACEBO;

AKATHISIA; ARTICLE; CONTROLLED CLINICAL TRIAL (TOPIC); DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG TOLERABILITY; HUMAN; INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY; MAJOR DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY (TOPIC); POST HOC ANALYSIS; PRIORITY JOURNAL; SUICIDAL IDEATION; SUICIDE; TREATMENT FAILURE; UNITED STATES;

ADULT; AGE FACTORS; AKATHISIA, DRUG-INDUCED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; HUMANS; MALE; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; QUINOLONES; SUICIDAL IDEATION; TIME FACTORS; YOUNG ADULT;

EID: 79955509217     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09m05495gre     Document Type: Article

References (30)

1. Asnis GM, Friedman TA, Sanderson WC, et al. Suicidal behaviors in adult psychiatric outpatients, part I: description and prevalence. Am J Psychiatry. 1993;150(1):108-112. (Pubitemid 23059173)
2. Gladstone GL, Mitchell PB, Parker G, et al. Indicators of suicide over 10 years in a specialist mood disorders unit sample. J Clin Psychiatry. 2001; 62(12):945-951. (Pubitemid 34007959)
3. Oquendo MA, Galfalvy H, Russo S, et al. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry. 2004;161(8):1433-1441. (Pubitemid 38989097)
4. Sokero TP, Melartin TK, Rytsälä HJ, et al. Suicidal ideation and attempts among psychiatric patients with major depressive disorder. J Clin Psychiatry. 2003;64(9):1094-1100. (Pubitemid 37158256)
5. Chen YW, Dilsaver SC. Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other Axis I disorders. Biol Psychiatry. 1996;39(10):896-899. (Pubitemid 26163536)
6. The Office of Applied Studies Report. Suicidal thoughts, suicide attempts, major depressive episode, and substance use among adults. Substance Abuse and Mental Health Services Administration (SAMHSA) 2006; Issue 34. http://www.oas.samhsa.gov/2k6/suicide/suicide.htm. Accessed 30 June 2009.
7. Centers for Disease Control and Prevention Office of Statistics and Programming. National Center for Injury Prevention and Control Web-based Injury Statistics Query and Reporting System (WISQARS): nonfatal injury reports 2007. http://webappa.cdc.gov/sasweb/ncipc/nfirates2001.html. Accessed 30 June 2009.
8. Centers for Disease Control and Prevention Office of Statistics and Programming. National Center for Injury Prevention and Control Web-Based Injury Statistics Query and Reporting System (WISQARS): leading causes of death, United States 2006. http://webappa.cdc.gov/sasweb/ncipc/leadcaus10.html. Accessed 30 June 2009.
9. Joiner TE Jr, Brown JS, Wingate LR. The psychology and neurobiology of suicidal behavior. Annu Rev Psychol. 2005;56(1):287-314. (Pubitemid 40300787)
10. Khan A, Khan S, Kolts R, et al. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry. 2003;160(4):790-792. (Pubitemid 41079617)
11. Gibbons RD, Hur K, Bhaumik DK, et al. The relationship between antide-pressant medication use and rate of suicide. Arch Gen Psychiatry. 2005; 62(2):165-172. (Pubitemid 40189132)
12. Olfson M, Shaffer D, Marcus SC, et al. Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry. 2003;60(10):978-982. (Pubitemid 37222079)
13. Gibbons RD, Brown CH, Hur K, et al. Relationship between antide-pressants and suicide attempts: an analysis of the Veterans Health Administration data sets. Am J Psychiatry. 2007;164(7):1044-1049. (Pubitemid 47121393)
14. Angst J, Angst F, Gerber-Werder R, et al. Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up. Arch Suicide Res. 2005;9(3):279-300. (Pubitemid 40977549)
15. Berman RM, Marcus RN, Swanink R, et al. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2007;68(6):843-853. (Pubitemid 47015482)
16. Marcus RN, McQuade RD, Carson WH, et al. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol. 2008;28(2):156-165. (Pubitemid 351417120)
17. Berman RM, Fava M, Thase ME, et al. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants. CNS Spectr. 2009; 14(4):197-206.
18. Thase ME, Trivedi MH, Nelson JC, et al. Examining the efficacy of adjunctive aripiprazole in major depressive disorder: a pooled analysis of 2 studies. Prim Care Companion J Clin Psychiatry. 2008;10(6):440-447.
19. Nelson JC, Thase ME, Trivedi MH, et al. Safety and tolerability of adjunctive aripiprazole in major depressive disorder: a pooled post hoc analysis (studies CN138-139 and CN138-163). Prim Care Companion J Clin Psychiatry. 2009;11(6):344-352.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
21. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382-389. (Pubitemid 9136500)
22. Rush AJ, Gullion CM, Basco MR, et al. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med. 1996; 26(3):477-486. (Pubitemid 26142491)
23. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry. 1989;154(5):672-676. (Pubitemid 19154942)
24. Friedman RA, Leon AC. Expanding the black box - depression, antidepressants, and the risk of suicide. N Engl J Med. 2007;356(23):2343-2346. (Pubitemid 46883767)
25. Olfson M, Marcus SC. A case-control study of antidepressants and attempted suicide during early phase treatment of major depressive episodes. J Clin Psychiatry. 2008;69(3):425-432. (Pubitemid 351549396)
26. Deisenhammer EA, Ing CM, Strauss R, et al. The duration of the suicidal process: how much time is left for intervention between consideration and accomplishment of a suicide attempt? J Clin Psychiatry. 2009;70(1): 19-24.
27. Hansen L. A critical review of akathisia, and its possible association with suicidal behaviour. Hum Psychopharmacol. 2001;16(7):495-505. (Pubitemid 33014646)
28. Müller-Oerlinghausen B, Berghöfer A. Antidepressants and suicidal risk. J Clin Psychiatry. 1999;60(suppl 2):94-99, discussion 111-116.
29. Rutherford BR, Sneed JR, Roose SP. Does study design influence outcome? the effects of placebo control and treatment duration in antidepressant trials. Psychother Psychosom. 2009;78(3):172-181.
30. Fava M, Evins AE, Dorer DJ, et al. The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach. Psychother Psychosom. 2003;72(3):115-127. (Pubitemid 36469860)